{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:42:28Z","timestamp":1773373348610,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Commission of Shanghai","award":["20DZ22708"],"award-info":[{"award-number":["20DZ22708"]}]},{"name":"Science and Technology Commission of Shanghai","award":["20DZ22708"],"award-info":[{"award-number":["20DZ22708"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03582-6","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T17:01:45Z","timestamp":1699376505000},"page":"533-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictive model for the progression of inactive thyroid eye disease: a retrospective study"],"prefix":"10.1007","volume":"84","author":[{"given":"Lingzi","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"issue":"5","key":"3582_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.13524","volume":"292","author":"L Bartalena","year":"2022","unstructured":"L. Bartalena, M.L. Tanda, Current concepts regarding Graves\u2019 orbitopathy. J. Intern. Med. 292(5), 692\u2013716 (2022)","journal-title":"J. Intern. Med."},{"key":"3582_CR2","doi-asserted-by":"crossref","unstructured":"Lei, C. et al. Facial expression of patients with Graves\u2019 orbitopathy. J. Endocrinol. Invest. 2023","DOI":"10.1007\/s40618-023-02054-y"},{"issue":"8","key":"3582_CR3","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1038\/s41433-020-01246-7","volume":"35","author":"B Du","year":"2021","unstructured":"B. Du et al. Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases. Eye (Lond.) 35(8), 2294\u20132301 (2021)","journal-title":"Eye (Lond.)"},{"issue":"1","key":"3582_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-023-01073-3","volume":"22","author":"X Huang","year":"2023","unstructured":"X. Huang et al. The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy. Biomed. Eng. Online 22(1), 7 (2023)","journal-title":"Biomed. Eng. Online"},{"issue":"5","key":"3582_CR5","doi-asserted-by":"publisher","first-page":"e0176064","DOI":"10.1371\/journal.pone.0176064","volume":"12","author":"Q Li","year":"2017","unstructured":"Q. Li et al. Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. PLoS One 12(5), e0176064 (2017)","journal-title":"PLoS One"},{"issue":"3-4","key":"3582_CR6","first-page":"177","volume":"5","author":"FF Rundle","year":"1945","unstructured":"F.F. Rundle, C.W. Wilson, Development and course of exophthalmos and ophthalmoplegia in Graves\u2019 disease with special reference to the effect of thyroidectomy. Clin. Sci. 5(3-4), 177\u2013194 (1945)","journal-title":"Clin. Sci."},{"issue":"4","key":"3582_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ophtha.2021.10.017","volume":"129","author":"RS Douglas","year":"2022","unstructured":"R.S. Douglas et al. Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and re-treatment: OPTIC-X study. Ophthalmology 129(4), 438\u2013449 (2022)","journal-title":"Ophthalmology"},{"issue":"12","key":"3582_CR8","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1089\/thy.2022.0280","volume":"32","author":"HY Ahn","year":"2022","unstructured":"H.Y. Ahn, J. Lee, J.K. Lee, Predictive model for Graves\u2019 ophthalmopathy in patients with new-onset Graves\u2019 disease. Thyroid 32(12), 1559\u20131567 (2022)","journal-title":"Thyroid"},{"issue":"6","key":"3582_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-18-0039","volume":"178","author":"W Wiersinga","year":"2018","unstructured":"W. Wiersinga et al. Predictive score for the development or progression of Graves\u2019 orbitopathy in patients with newly diagnosed Graves\u2019 hyperthyroidism. Eur. J. Endocrinol. 178(6), 635\u2013643 (2018)","journal-title":"Eur. J. Endocrinol."},{"key":"3582_CR10","doi-asserted-by":"crossref","unstructured":"H.J. Byeon et al. Preoperative risk factors for proptosis recurrence after rehabilitative orbital decompression in Graves\u2019 orbitopathy patients. Am. J. Ophthalmol. 2023","DOI":"10.1016\/j.ajo.2023.07.020"},{"issue":"4","key":"3582_CR11","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"L. Bartalena et al. The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur. J. Endocrinol. 185(4), G43\u2013g67 (2021)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"3582_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0240-8","volume":"18","author":"Y Wang","year":"2018","unstructured":"Y. Wang et al. A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy. BMC Endocr. Disord. 18(1), 13 (2018)","journal-title":"BMC Endocr. Disord."},{"issue":"2","key":"3582_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0889-8529(18)30485-7","volume":"16","author":"RS Bahn","year":"1987","unstructured":"R.S. Bahn, C.A. Gorman, Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol. Metab. Clin. North Am. 16(2), 391\u2013407 (1987)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"9","key":"3582_CR14","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1210\/jc.2005-0507","volume":"90","author":"P Perros","year":"2005","unstructured":"P. Perros et al. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves\u2019 ophthalmopathy. J. Clin. Endocrinol. Metab. 90(9), 5321\u20135323 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3582_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/thy.2013.0240","volume":"24","author":"F Menconi","year":"2014","unstructured":"F. Menconi et al. Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: Rundle\u2019s curve revisited. Thyroid 24(1), 60\u201366 (2014)","journal-title":"Thyroid"},{"issue":"10","key":"3582_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/BF03350047","volume":"12","author":"L Bartalena","year":"1989","unstructured":"L. Bartalena et al. More on smoking habits and Graves\u2019 ophthalmopathy. J. Endocrinol. Invest 12(10), 733\u2013737 (1989)","journal-title":"J. Endocrinol. Invest"},{"issue":"4","key":"3582_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","volume":"45","author":"J Pfeilschifter","year":"1996","unstructured":"J. Pfeilschifter, R. Ziegler, Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin. Endocrinol. (Oxf.) 45(4), 477\u2013481 (1996)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"3582_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.1993.03500040045034","volume":"269","author":"MF Prummel","year":"1993","unstructured":"M.F. Prummel, W.M. Wiersinga, Smoking and risk of Graves\u2019 disease. Jama 269(4), 479\u2013482 (1993)","journal-title":"Jama"},{"issue":"3","key":"3582_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.eprac.2020.11.011","volume":"27","author":"MH Lee","year":"2021","unstructured":"M.H. Lee et al. Risk factors of thyroid eye disease. Endocr. Pr. 27(3), 245\u2013253 (2021)","journal-title":"Endocr. Pr."},{"key":"3582_CR20","doi-asserted-by":"publisher","first-page":"4676289","DOI":"10.1155\/2016\/4676289","volume":"2016","author":"HC Kau","year":"2016","unstructured":"H.C. Kau et al. Cigarette smoke extract-induced oxidative stress and fibrosis-related genes expression in orbital fibroblasts from patients with Graves\u2019 ophthalmopathy. Oxid. Med. Cell Longev. 2016, 4676289 (2016)","journal-title":"Oxid. Med. Cell Longev."},{"issue":"1","key":"3582_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/WCO.0000000000000894","volume":"34","author":"BT Johnson","year":"2021","unstructured":"B.T. Johnson, E. Jameyfield, V.K. Aakalu, Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment. Curr. Opin. Neurol. 34(1), 116\u2013121 (2021)","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"3582_CR22","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/thy.2017.0126","volume":"27","author":"SH Yu","year":"2017","unstructured":"S.H. Yu et al. Clinical Implications of Immunoglobulin G4 to Graves\u2019 Ophthalmopathy. Thyroid 27(9), 1185\u20131193 (2017)","journal-title":"Thyroid"},{"issue":"4S Suppl 1","key":"3582_CR23","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/IOP.0000000000001053","volume":"34","author":"T Diana","year":"2018","unstructured":"T. Diana, G.J. Kahaly, Thyroid stimulating hormone receptor antibodies in thyroid eye disease-methodology and clinical applications. Ophthalmic Plast. Reconstr. Surg. 34(4S Suppl 1), S13\u2013s19 (2018)","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"issue":"3","key":"3582_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","volume":"133","author":"JD Stein","year":"2015","unstructured":"J.D. Stein et al. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. JAMA Ophthalmol. 133(3), 290\u2013296 (2015)","journal-title":"JAMA Ophthalmol."},{"issue":"5","key":"3582_CR25","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1210\/clinem\/dgab070","volume":"106","author":"A Nilsson","year":"2021","unstructured":"A. Nilsson, K. Tsoumani, T. Planck, Statins decrease the risk of orbitopathy in newly diagnosed patients with Graves disease. J. Clin. Endocrinol. Metab. 106(5), 1325\u20131332 (2021)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03582-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T06:19:19Z","timestamp":1715062759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03582-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["3582"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03582-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]},"assertion":[{"value":"7 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Shanghai Ninth People\u2019s Hospital (Approval No.: SH9H-2022-T161-2).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}